Research and Markets (http://www.researchandmarkets.com/research/41a43f/the_top_10_pharmac) has announced the addition of the "The Top 10 Pharmaceutical Companies in India: Growth Strategies, Performance and SWOT Analyses" report to their offering.
The leading players in the Indian pharmaceutical market comprise both India-based and MNCs. This report provides an insight to the current state of Indian pharmaceutical industry as well as the evolving trends. This report analyzes the Indian pharmaceutical industry in light of market size, key drivers and resistors, trends and competitive positioning in the global market. It also analyzes the competitive landscape of the industry based on financial and operational (field force strength, R&D spend, exposure to chronic therapeutic areas and the US pharmaceutical market) parameters.
This report also compares and analyzes the competitive positioning of Indian pharmaceutical market in the context of global pharmaceutical market. The report also includes profiles of the top ten companies in the industry and also involves a brief summary of top 11 to 20 players.
The top 10 companies in the Indian pharmaceutical industry were assessed on following parameters:
- market share in the Indian pharmaceutical market;
- marketed products and therapeutic focus;
- growth strategies and major acquisitions and divestments in this market;
- key partnerships and alliances formed by these companies;
- business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.
Key findings:
- The Indian pharmaceutical market was valued at $7,743m in 2008, an increase of 4.0% over 2007. Business Insights anticipates that Indian pharmaceutical market will grow at a faster pace than the global pharmaceutical market, approximately at a CAGR of 13.2% during 2009-14 to reach a total value of $15,490m in 2014.
- India has emerged as a key destination for global pharmaceutical companies due to its high growth prospects led by ageing population, changing disease profile, and improving patent regime and socio-economic conditions.
- The Indian pharmaceutical market is highly competitive and fragmented with the top 10 players accounting for 36.1% of the total R&H sales in 2008.
- India started to comply with World Trade Organization's Trade Related Aspects of Intellectual Property Rights (WTO-TRIPS) agreement and recognized product patents with the amendment of the Indian Patent Act in January 2005. Indian companies plan to capitalize on Japanese government initiatives to promote generic drugs to reduce healthcare costs.
Key issues: